
Oils
Test 350
A high-concentration testosterone blend formulated for advanced research protocols needing larger total doses.
Test 350 is a high-concentration testosterone preparation at 350mg/ml, formulated to deliver a substantial total dose per injection with reduced oil volume. As with other testosterone products, the compound drives its effects through androgen receptor binding once absorbed from the injection site. The manufacturer has not published a detailed ester breakdown or independent half-life data for this specific blend; researchers accustomed to standard single-ester testosterone kinetics (roughly 4-10 days depending on ester) should treat dosing frequency accordingly until further data is available.
Specifications
Research Benefits
- High concentration — 350mg/ml reduces the injection volume needed for larger total doses.
- Core testosterone effects — Supports the same nitrogen retention and protein synthesis pathway studied across the testosterone class.
- Advanced-protocol utility — Formulated for researchers already familiar with higher-dose testosterone administration.
How It Works
Because the specific ester composition of this blend is not published in detail, its exact release curve cannot be characterised as precisely as single-ester products like Enanthate or Cypionate. Researchers should approach dosing intervals conservatively until more granular pharmacokinetic data is available.
⚠ For Research Use Only
By purchasing, the buyer confirms this product is being acquired for legitimate research purposes and assumes full responsibility for its handling, storage, and use in compliance with all applicable local, national, and international laws.
More Oils

Oils
Boldenone Undecylenate (EQ)
Equipoise, a long-acting testosterone derivative studied for lean gains, endurance and red blood cell increases.
View
Oils
DHB (1-Testosterone)
Dihydroboldenone, a potent non-aromatising DHT-class compound studied for lean mass and strength research.
View
Oils
Fem-Test
A low-dose 10mg/ml testosterone formulation designed for female-specific research dosing protocols.
View